Statement Of Cash Flows [Abstract]

BioArctic - Filing #688739

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-01-01
As at
2020-01-01
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations
31 638 SEK
140 457 SEK
Interest paid, classified as operating activities
751,000 SEK
984,000 SEK
Interest received, classified as operating activities
2 535 SEK
388,000 SEK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
12 746 SEK
4 386 SEK
Other inflows (outflows) of cash, classified as investing activities
18,000 SEK
27,000 SEK
Cash flows from (used in) investing activities
12 763 SEK
4 412 SEK
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities
8 793 SEK
7 389 SEK
Dividends paid, classified as financing activities
5 985 SEK
- SEK
Cash flows from (used in) financing activities
2 808 SEK
7 389 SEK
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
47 209 SEK
152 257 SEK
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
4 190 SEK
723,000 SEK
Cash and cash equivalents
805 386 SEK
848 405 SEK
848 405 SEK
999 940 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.